These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 36189478)
1. Detrimental Effect of the Film Coat Chemistry and Thickness on the Physical Stability of Amorphous Solid Dispersions in Tablet Formulations. Punia A; Biyyala V; Faassen F; Ash J; Lamm MS J Pharm Sci; 2023 Mar; 112(3):708-717. PubMed ID: 36189478 [TBL] [Abstract][Full Text] [Related]
2. High Bulk-Density Amorphous Dispersions to Enable Direct Compression of Reduced Tablet Size Amorphous Dosage Units. Frank DS; Nie H; Chandra A; Coelho A; Dalton C; Dvorak H; Elkhabaz A; Fahy M; Ormes J; Parker A; Punia A; Rowe J; Schenck L; Smith D; Strotman NA; Wang M; Wareham L J Pharm Sci; 2023 Aug; 112(8):2037-2045. PubMed ID: 36115592 [TBL] [Abstract][Full Text] [Related]
3. Combining crystalline and polymeric excipients in API solid dispersions - Opportunity or risk? Veith H; Wiechert F; Luebbert C; Sadowski G Eur J Pharm Biopharm; 2021 Jan; 158():323-335. PubMed ID: 33296719 [TBL] [Abstract][Full Text] [Related]
4. The impact of diluents on the compaction, dissolution, and physical stability of amorphous solid dispersion tablets. Yu D; Hoag SW Int J Pharm; 2024 Apr; 654():123924. PubMed ID: 38395318 [TBL] [Abstract][Full Text] [Related]
5. Amorphous solid dispersion of nisoldipine by solvent evaporation technique: preparation, characterization, in vitro, in vivo evaluation, and scale up feasibility study. Chavan RB; Lodagekar A; Yadav B; Shastri NR Drug Deliv Transl Res; 2020 Aug; 10(4):903-918. PubMed ID: 32378174 [TBL] [Abstract][Full Text] [Related]
6. Investigation into the Solid-State Properties and Dissolution Profile of Spray-Dried Ternary Amorphous Solid Dispersions: A Rational Step toward the Design and Development of a Multicomponent Amorphous System. Baghel S; Cathcart H; O'Reilly NJ Mol Pharm; 2018 Sep; 15(9):3796-3812. PubMed ID: 30020788 [TBL] [Abstract][Full Text] [Related]
8. Effects of tablet formulation and subsequent film coating on the supersaturated dissolution behavior of amorphous solid dispersions. Sakai T; Hirai D; Kimura SI; Iwao Y; Itai S Int J Pharm; 2018 Apr; 540(1-2):171-177. PubMed ID: 29447848 [TBL] [Abstract][Full Text] [Related]
9. Pharmaceutical development of an amorphous solid dispersion formulation of elacridar hydrochloride for proof-of-concept clinical studies. Sawicki E; Schellens JH; Beijnen JH; Nuijen B Drug Dev Ind Pharm; 2017 Apr; 43(4):584-594. PubMed ID: 28010129 [TBL] [Abstract][Full Text] [Related]
10. Surface Stabilization and Dissolution Rate Improvement of Amorphous Compacts with Thin Polymer Coatings: Can We Have It All? Novakovic D; Peltonen L; Isomäki A; Fraser-Miller SJ; Nielsen LH; Laaksonen T; Strachan CJ Mol Pharm; 2020 Apr; 17(4):1248-1260. PubMed ID: 32027513 [TBL] [Abstract][Full Text] [Related]
11. Recent Advances in Understanding the Micro- and Nanoscale Phenomena of Amorphous Solid Dispersions. Ricarte RG; Van Zee NJ; Li Z; Johnson LM; Lodge TP; Hillmyer MA Mol Pharm; 2019 Oct; 16(10):4089-4103. PubMed ID: 31487183 [TBL] [Abstract][Full Text] [Related]
12. Development of an Amorphous Solid Dispersion Formulation for Mitigating Mechanical Instability of Crystalline Form and Improving Bioavailability for Early Phase Clinical Studies. Chiang CW; Lubach JW; Chen T; Chin S; Ly J; Zhang W; Hou HH; Nagapudi K Mol Pharm; 2023 May; 20(5):2452-2464. PubMed ID: 37010134 [TBL] [Abstract][Full Text] [Related]
13. Solvent influence on manufacturability, phase behavior and morphology of amorphous solid dispersions prepared via bead coating. Boel E; Giacomini F; Van den Mooter G Eur J Pharm Biopharm; 2021 Oct; 167():175-188. PubMed ID: 34325003 [TBL] [Abstract][Full Text] [Related]
14. Formulation and process design for a solid dosage form containing a spray-dried amorphous dispersion of ibipinabant. Leane MM; Sinclair W; Qian F; Haddadin R; Brown A; Tobyn M; Dennis AB Pharm Dev Technol; 2013; 18(2):359-66. PubMed ID: 22268601 [TBL] [Abstract][Full Text] [Related]
15. Surface nanocoating of high drug-loading spray-dried amorphous solid dispersions by atomic layer coating: Excellent physical stability under accelerated storage conditions for two years. Van Duong T; Nguyen HT; Wang F; Wang M; Narwankar PK; Taylor LS Int J Pharm; 2022 May; 620():121747. PubMed ID: 35427750 [TBL] [Abstract][Full Text] [Related]
16. The Implications of Drug-Polymer Interactions on the Physical Stability of Amorphous Solid Dispersions. Bookwala M; Wildfong PLD Pharm Res; 2023 Dec; 40(12):2963-2981. PubMed ID: 37389801 [TBL] [Abstract][Full Text] [Related]
17. Downstream processing of polymer-based amorphous solid dispersions to generate tablet formulations. Démuth B; Nagy ZK; Balogh A; Vigh T; Marosi G; Verreck G; Van Assche I; Brewster ME Int J Pharm; 2015; 486(1-2):268-86. PubMed ID: 25827903 [TBL] [Abstract][Full Text] [Related]